Three-year Results of Combined Modality Therapy in Locally Advanced, Resectable Squamous Cell Carcinoma of the Head and Neck

References

• Amer M. H., Izbicki R. M., Vaitkevicius V. K., Al-Sarraf M. Combination chemotherapy with cw-diammine-dichloroplatinum, Oncovin, and bleomycin (COB) in advanced head and neck cancer. Phase II. Cancer 1980; 45: 217
   PubMedGoogle Scholar
• Böheim K., Böheim C., Rauchegger H. Zytostatische Induktionstherapie mit Ci'j-Platinum bei Kopf-Halstumoren. Erste klinische Erfahrungen und histologische Untersuchungen. Arch Otorhinolaryngol 1981; 233: 31
   PubMedGoogle Scholar
• Böheim K., Mikuz G., Böheim C. Pathohistologische Veränderungen nach zytostatischer Induktionstherapie mit Methotrexat (M), Bleomycin (B) und Cisplatin (P) (MBP). Laryng Rhinol 1982; 61: 246
   PubMedGoogle Scholar
• Coates H. L., De Santo L. W., Devine K. D., Elveback L. R. Carcinoma of the supraglottic larynx. Arch Otolaryngol 1976; 102: 686
   PubMedGoogle Scholar
• Crissman J. D., Gluckman J., Whiteley J., Quenelle D. Squamous cell carcinoma of the floor of the mouth. Head & Neck Surg 1980; 3: 2
   PubMedGoogle Scholar
• Cutler S. J., Ederer F. Maximum utilization of the life table method in analyzing survival. J Chron Dis 1958; 8: 699
   PubMedGoogle Scholar
• Ervin T. J., Weichselbaum R., Miller D., Meshad M., Posner M., Fabian R. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM). Cancer Treat Rep 1981; 65: 787
   PubMedGoogle Scholar
• Ganzer U., Sendrowski P., Vosteen K. H., Meyer-Breiting P. Die kombinierte radiochi- rurgische Behandlung des fortgeschrittenen Kehlkopfkarzinoms (T3–4 N0–3). Ein retrospektiver Vergleich zwischen Sandwich-Technik und postoperativer Bestrahlung. Laryng Rhinol 1981; 60: 63
   PubMedGoogle Scholar
• Kirchner A., Owen J. R. Five hundred cancers of the larynx and pyriform sinus. Results of treatment by radiation and surgery. Laryngoscope 1977; 87: 1288
   PubMed Web of Science ®Google Scholar
• Mann W., Laniado K., Kiefer K. Rezidive bei oropharyngealen, hypopharyngealen und supraglottischen Plattenepithelkarzinomen. Laryng Rhinol 1980; 59: 652
   PubMedGoogle Scholar
• Marks J. E., Kurnik B., Powers W. E., Ogura J. H. Carcinoma of the pyriform sinus. An analysis of treatment results and patterns of failure. Cancer 1978; 41: 1008
   PubMed Web of Science ®Google Scholar
• Mead G. M., Jacobs C. Changing role of chemotherapy in treatment of head and neck cancer. Am J Med 1982; 73: 582
   PubMed Web of Science ®Google Scholar
• Muggia M. F., Rosencweig M., Louie E. A. Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced disease. Head Neck Surg 1980; 2: 196
   PubMedGoogle Scholar
• Peppard S. B., Al-Sarraf M., Powers W. E., Loh J. K., Weaver A. W. Combination of cis- platinum, Oncovin, and bleomycin (COB) prior to surgery and/or radiotherapy in advanced untreated epidermoid cancer of the head and neck. Laryngoscope 1980; 90: 1273
   PubMedGoogle Scholar
• Price L. A., Hill B. T. Safe and effective induction chemotherapy without cisplatin for squamous cell carcinoma of the head and neck: impact on complete response rate and survival at five years, following local therapy. Med Pediatr Oncol (USA) 1982; 10: 535
   PubMedGoogle Scholar
• Probert J.C, Thompson R. W., Bagshaw M. A. Patterns of spread of distant metastases in head and neck cancer. Cancer 1974; 33: 127
   PubMedGoogle Scholar
• Rosemann G., Streckbein R. G., Vosteen K. H. Verbesserte Prognose der malignen Oropharynxtumoren durch präoperative Radiotherapie. Laryng Rhinol 1976; 55: 567
   PubMedGoogle Scholar
• Shapshey S. M., Hong K. W., Incze J. S., Sismanis A., Bhutani R., Vaughn C. W., Strong M. S. Prognostic indicators in induction ci's-platinum bleomycin chemotherapy for advanced head and neck cancer. Am J Surg 1980; 140: 543
   PubMedGoogle Scholar
• Spaulding M. B., Kahn A., De los Santos R., Klotch D., Lore J. M. Adjuvant chemotherapy in advanced head and neck cancer. An up date. Am J Surg 1982; 144: 432
   PubMed Web of Science ®Google Scholar
• TNM: Klassifikation der malignen Tumoren (UJCC, Internat. Union against Cancer)3rd revised and enlarged edition. Springer, Berlin, Heidelberg, New York 1979
   Google Scholar
• Trible W. M. Cancer of the oral cavity. Five year end results in 237 patients. Ann Owl 1969; 78: 716
   Google Scholar
• Vogl S. E., Lerner H., Kaplan B. H., Camacho F., Cinberg J., Schoenfeld D. Mitomycin- C, methotrexate, bleomycin and c/s-diamminedichloroplatinum II in the chemotherapy of advanced squamous cancer of the head and neck. Cancer 1982; 50: 6
   PubMedGoogle Scholar
• Vogl S. E., Lerner H., Kaplan B. H., Coughlin C, McCormick B., Camacho F., Cinberg J. Failure of effective initial chemotherapy to modify the course of stage IV (Mo) squamous cancer of the head and neck. Cancer 1982; 50: 840
   PubMed Web of Science ®Google Scholar
• Weaver A., Lohn J. J. K., Vandenberg H., Powers W., Flemming S., Mathog R., Al-Sarraf M. Combined modality therapy for advanced head and neck cancer. Am J Surg 1980; 140: 549
   PubMedGoogle Scholar
• Weichselbaum R. R., Posner M. R., Ervin T. J., Fabian R. L., Miller D. Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancer. Int J Radiation Oncology Biol Phys 1982; 8: 909
   PubMedGoogle Scholar
• Weidauer H., Singer R. Ergebnisse einer primären antineoplastischen Chemotherapie bei fortgeschrittenen verhornenden Plattenepithelkarzinomen im Kopf-Hals-Bereich. Laryng Rhinol 1981; 60: 151
   PubMedGoogle Scholar